You Searched For: mycoplasma+detection
4 867 results were found
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/nl/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Downstream purification for vaccines
/cms/en/bioprocessing_vaccines_downstream_purification
Downstream purification for vaccines During subsequent steps for vaccine concentration and clarification followed by passage through several filtration steps and chromatography columns it is critical that vaccine purity potency and consistency be ...
Upstream processing for mAbs
/cms/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for mAbs
/cms/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for mAbs
/cms/it/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Downstream purification for mAbs
/cms/bioprocessing_mabs_downstream_purification
Downstream purification for mAbs Major processes including affinity ion exchange HIC and size exclusion require chromatography resins and process buffers. These products help ensure that the quality of the target mAb is maintained through each ste...
Downstream purification for mAbs
/cms/bioprocessing_mabs_downstream_purification
Downstream purification for mAbs Major processes including affinity ion exchange HIC and size exclusion require chromatography resins and process buffers. These products help ensure that the quality of the target mAb is maintained through each ste...
Upstream processing for mAbs
/cms/en/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for mAbs
/cms/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
385 - 400 of 4 867